10-Q: LivePerson Q2 2025: Revenue Drops 25%, Net Loss Widens

LivePerson, Inc. reported a 25% decline in revenue for the second quarter of 2025, alongside a significant net loss, as customer uncertainty and macroeconomic factors impacted business.

Summary

• Revenue decreased by 25% to $59.6 million for the three months ended June 30, 2025, and to $124.3 million for the six months ended June 30, 2025, compared to the prior year periods.
• Net loss for the three months ended June 30, 2025, was $15.7 million, a significant shift from a net income of $41.8 million in the comparable 2024 period, which included a $73.1 million gain on debt extinguishment.
• Net loss for the six months ended June 30, 2025, was $29.8 million, compared to a net income of $6.2 million in the comparable 2024 period.
• Basic net loss per share was $0.17 for the three months and $0.32 for the six months ended June 30, 2025.
• Cash and cash equivalents decreased by $21.3 million to $162.0 million as of June 30, 2025, from $183.2 million at December 31, 2024.
• Average Annual Revenue Per Enterprise and Mid-market Customer (ARPC) increased to approximately $655,000 for the trailing twelve months ended June 30, 2025, from $630,000 in the prior year.
• Revenue retention for enterprise and mid-market customers was approximately 78% in Q2 2025, significantly below the target range of 105% to 115%.
• Total liabilities increased to $686.6 million as of June 30, 2025, from $675.1 million at December 31, 2024, while total stockholders' equity deepened its deficit to $(82.4) million from $(67.3) million.

Sentiment

Score: 2

Explanation: The company's financial performance is severely deteriorating, marked by a substantial 25% revenue decline and a widening net loss. Customer retention is alarmingly low at 78%, far below the target, indicating significant churn and an inability to secure new business due to perceived financial instability and macroeconomic headwinds. The Nasdaq delisting notice poses an immediate and severe threat to liquidity and investor confidence. While debt restructuring is underway, the terms involve substantial dilution for existing shareholders and highlight the company's precarious financial position. The accumulated deficit continues to grow, and despite improved cash flow from operations, the overall outlook is highly negative, suggesting further downside risk for the stock.

Positives

• Operating loss improved to $(6.4) million for the three months ended June 30, 2025, from $(29.8) million in the comparable 2024 period.
• Net cash used in operating activities improved to $(14.8) million for the six months ended June 30, 2025, from $(16.8) million in the comparable 2024 period.
• Net cash provided by financing activities was $0.4 million for the six months ended June 30, 2025, a significant improvement from $31.8 million cash used in the comparable 2024 period.
• Average Annual Revenue Per Enterprise and Mid-market Customer (ARPC) increased to approximately $655,000 for the trailing twelve months ended June 30, 2025.
• General and administrative expenses decreased by 67% to $7.9 million for the three months ended June 30, 2025, primarily due to lower legal, consulting, and bad debt expenses.
• Restructuring costs decreased significantly by 82% to $0.6 million for the three months ended June 30, 2025, indicating a winding down of major restructuring activities.
• The company settled the Starboard Value LP litigation in July 2025, with costs covered by insurance, and the Damri stockholder class action was dismissed with prejudice, though an appeal is pending.

Negatives

• Revenue decreased by 25% for both the three and six months ended June 30, 2025, primarily due to customer cancellations, downsells, and reduced variable usage.
• Net loss widened to $15.7 million for the three months and $29.8 million for the six months ended June 30, 2025, compared to net income in the prior year, largely due to the absence of a significant one-time gain on debt extinguishment from 2024.
• Revenue retention for enterprise and mid-market customers was approximately 78% in Q2 2025, falling significantly short of the target range of 105% to 115%.
• Customer uncertainty regarding financial stability and broader macroeconomic factors are extending enterprise buying cycles, leading to slower new business bookings.
• Interest expense increased significantly by 284% to $7.9 million for the three months ended June 30, 2025, and by 458% to $15.3 million for the six months ended June 30, 2025, primarily due to new debt instruments.
• Total stockholders' equity is a deficit of $(82.4) million as of June 30, 2025, worsening from $(67.3) million at December 31, 2024.
• The company received a Nasdaq notification on May 1, 2025, regarding its common stock closing bid price being below $1.00 for 30 consecutive trading days, risking delisting.

Risks

• Failure to regain compliance with Nasdaq's minimum bid price requirement could lead to delisting of common stock.
• Delisting from Nasdaq would negatively affect share price, trading volume, liquidity, and ability to raise additional capital.
• Delisting would constitute a 'Fundamental Change' under the indentures governing the 2026 Notes and 2029 Notes, potentially triggering repurchase obligations.
• If more than $60.0 million principal amount of 2026 Notes remains outstanding 91 days prior to their maturity date, the 2029 Notes will immediately become due and payable.
• The company is subject to ongoing legal proceedings, including a pending appeal in the Damri stockholder class action and other derivative actions, which could result in defense/settlement costs, diversion of management resources, and reputational risks.
• Governmental inquiries related to previous COVID-19 products and services could lead to adverse impacts.
• Customer uncertainty regarding the company's financial stability and broader macroeconomic factors are impacting revenue retention and new business bookings.
• The company has an accumulated deficit of $1,021.1 million as of June 30, 2025, and has historically incurred net losses and negative cash flows.
• The company may require additional funds for operations, expansion, or acquisitions, and there is no assurance that additional funding will be available on favorable terms, if at all.
• The 2029 Notes indenture contains restrictive covenants, including limitations on debt, liens, and dividends, and requires maintaining a minimum cash balance of $60.0 million.

Future Outlook

Management anticipates that current cash and cash equivalents will be sufficient to satisfy working capital and capital requirements for at least the next 12 months. The company plans to refinance the remaining balance of the 2026 Notes on or prior to their maturity. However, there is no assurance that additional funding will be available on favorable terms, if needed for expansion or new services. The company is evaluating the potential impacts of the One Big Beautiful Bill Act (OBBBA) on its consolidated financial statements, with effective dates varying between 2025 and 2027.

Management Comments

• ARPC and revenue retention are currently the key performance metrics our management uses to assess the health and trajectory of the Company.
• We have observed heightened renewal hesitation and slower than anticipated new business bookings, primarily driven by customer uncertainty regarding our financial stability as well as broader macroeconomic factors extending enterprise buying cycles.

Industry Context

LivePerson operates as a leader in digital customer conversation, leveraging its platform to integrate human agents, proprietary AI, third-party bots, and Large Language Models (LLMs) to scale automations across customer interactions. The company's focus on AI-powered conversations aligns with broader industry trends towards enhanced automation and efficiency in customer engagement. However, the company notes that macroeconomic factors are extending enterprise buying cycles, impacting new business bookings across the industry.

Corporate Governance

Legal Proceedings

• Damri v. LivePerson, Inc. (stockholder class action): Complaint alleged false and misleading Form 10-Q filings and forecasts for fiscal year 2022. Court granted company's motion to dismiss with prejudice on March 19, 2025. Plaintiff filed a notice of appeal on April 17, 2025, which remains pending.
• Weissbrod v. LivePerson, Inc. (parallel Israeli litigation): Pending in Tel Aviv District Court, stayed pending developments in the Damri case.
• Marti v. LoCascio and four other purported derivative actions: Filed by stockholders against former CEO, CFO, and current/former directors, claiming harm to the company from the same acts as the Damri lawsuit. All are stayed or in abeyance pending further developments in the Damri case.
• Starboard Value LP v. LivePerson, Inc.: Lawsuit alleging common law fraud, fraudulent inducement, and negligent misrepresentation related to a 2022 proxy contest settlement. Settled in July 2025, with costs covered by insurance.
• COVID-Related Matters: Company previously provided COVID-19 testing products/services, which are subject to inquiry and review by Medicare, Department of Justice, and U.S. Food and Drug Administration. Company has discontinued these offerings and is cooperating with inquiries.

Stakeholder Impact

• Shareholders: Significant negative impact due to substantial revenue decline, widening net loss, poor revenue retention, and the risk of Nasdaq delisting. The complex debt restructuring and potential dilution from new equity issuances (39% of fully diluted common stock) could further impact existing shareholders.
• Employees: Restructuring initiatives have led to workforce reductions, as indicated by decreased salary and employee-related expenses and severance costs, though the major restructuring activities were substantially completed by end of 2024.
• Customers: Customer uncertainty regarding the company's financial stability is explicitly cited as a factor for renewal hesitation and slower new business, indicating a potential erosion of trust or perceived risk in relying on the platform.
• Creditors (Noteholders): The company is actively engaging in complex debt restructuring, including exchanging 2026 Notes for new 2029 Notes, cash, and equity, which directly impacts their holdings and future repayment terms. The risk of 2029 Notes becoming due if 2026 Notes are not refinanced also impacts them.

Next Steps

• Regain compliance with Nasdaq's minimum bid price requirement (maintain $1.00+ for 10 consecutive trading days within 180 calendar days from May 1, 2025).
• Complete the privately negotiated exchange of approximately $341.1 million of 2026 Notes, expected prior to September 30, 2025.
• Refinance the remaining balance of the 2026 Notes on or prior to their maturity (December 15, 2026).
• Continue to cooperate with governmental inquiries related to previous COVID-19 product and service offerings.
• Evaluate the impacts of the One Big Beautiful Bill Act (OBBBA) on consolidated financial statements.

Key Dates

Recommendation

The company's financial performance is severely deteriorating, marked by a 25% revenue decline and a widening net loss. Customer retention is alarmingly low at 78%, far below the target, indicating significant churn and an inability to secure new business due to perceived financial instability and macroeconomic headwinds. The Nasdaq delisting notice poses an immediate and severe threat to liquidity and investor confidence. While debt restructuring is underway, the terms involve substantial dilution for existing shareholders and highlight the company's precarious financial position. The accumulated deficit continues to grow, and despite improved cash flow from operations, the overall outlook is highly negative, suggesting further downside risk for the stock.

Keywords

LivePerson, LPSN, SEC Filing, 10-Q, Quarterly Report, Financial Results, Revenue, Net Loss, Convertible Notes, Debt Restructuring, Nasdaq Delisting, AI, Customer Conversation, Enterprise Software, Financial Stability, Share Price, Corporate Governance, Legal Proceedings, Risk Factors